CS
LONA

Credit Suisse’s LeonaBio Inc LONA Stock Holding History

Credit Suisse’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– -$3 – 3292
2022
Q4 		– Sell
-19
Closed -$599 – 3859
2022
Q3 		$1K Buy
19
+16
+533% +$552 ﹤0.01% 3804
2022
Q2 		$0 Buy
+3
New +$275 ﹤0.01% 3917

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Credit Suisse's LONA Position: Q1 2023 in Review

Credit Suisse held its LeonaBio Inc (LONA) position steady in Q1 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3292.

Credit Suisse first reported a position in LONA in Q2 2022 and has held it in 2 quarters since. The position peaked at $1K in Q3 2022. 83 funds tracked by Wall St. Rank hold LONA as of Q1 2023.

  • Credit Suisse held 0 shares of LeonaBio Inc worth $0 as of Q1 2023.
  • Credit Suisse left its LeonaBio Inc share count unchanged in Q1 2023.
  • LeonaBio Inc made up ﹤0.01% of Credit Suisse's portfolio in Q1 2023, its #3292 holding.
  • Credit Suisse first reported a position in LeonaBio Inc in Q2 2022 and has held it in 2 quarters since.
  • Credit Suisse's LeonaBio Inc position peaked at $1K in Q3 2022.
  • 83 funds tracked by Wall St. Rank held LeonaBio Inc as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.